Drug Cos. Ask 3rd Circ. To Halt Trial For Class Cert. Fight
Mylan Inc. and Ranbaxy Laboratories Inc. have urged the Third Circuit to halt an upcoming pay-for-delay trial over Cephalon Inc.'s narcolepsy drug Provigil while the appeals court hears their challenge to...To view the full article, register now.
Already a subscriber? Click here to view full article